Medrix Clinical Research - About the company
Medrix Clinical Research is an unfunded company based in India, founded in 2005. It operates as a Provider of site management, record management, and equipment calibration services. Medrix Clinical Research has not raised any funding yet. The company has 773 active competitors, including 51 funded and 47 that have exited. Its top competitors include companies like Simulations Plus, Alloy Therapeutics and Maiva Pharma.
Company Details
Provider of site management, record management, and equipment calibration services. It offers site management solutions for clinical trials, including training and support staff. The company provides end-to-end physical document storage solutions designed to improve organizational efficiency. Additionally, it delivers medical equipment calibration services to ensure accuracy and adherence to industry standards.
Key Metrics
Sign up to download Medrix Clinical Research's company profile
Medrix Clinical Research's funding and investors
Medrix Clinical Research has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Medrix Clinical Research's Competitors and alternates
Top competitors of Medrix Clinical Research include Simulations Plus, Alloy Therapeutics and Maiva Pharma. Here is the list of Top 10 competitors of Medrix Clinical Research, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Simulations Plus 1996, Lancaster (United States), Public | Developer of modeling and simulation software and consulting services provider | - | 65/100 | |
2nd |  Alloy Therapeutics 2017, Lexington (United States), Series D | Provider of drug discovery services | $117M | 63/100 | |
3rd |  Maiva Pharma 1996, Hosur (India), Late Stage | Manufacturer of sterile injectables | $125M | 60/100 | |
4th |  Manifold Bio 2018, United States, Series A | Developer of tissue-targeted therapeutics using in vivo screening and AI design | $78.2M | 57/100 | |
5th | Biotechnology research company developing biological drugs | $160M | 56/100 | ||
6th |  Biocom California 1995, San Diego (United States), Acquired | CRO focused on drug discovery & development for multiple therapeutic areas | - | - | 55/100 |
7th |  Syenex 2022, Chicago (United States), Series B | Developer of cell-specific delivery systems and programmable cell engineering payloads | $13.7M | 54/100 | |
8th | Jubilant Biosys 2000, Noida (India), Unfunded | Provides drug discovery services from target discovery to candidate selection | - | - | 53/100 |
9th | Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus | $42.3M | 53/100 | ||
10th | Viva Biotech 2006, Shanghai (China), Public | Research services focused on drug discovery and development | - | 51/100 | |
709th | Medrix Clinical Research 2005, India, Unfunded | Provider of site management, record management, and equipment calibration services | - | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Medrix Clinical Research's competitors? Click here to see the top ones
Medrix Clinical Research's Investments and acquisitions
Medrix Clinical Research has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Medrix Clinical Research
Explore our recently published companies
- Psycofit.com - Unfunded company
- Veegotech.com - Unfunded company
- Retinascreen.com - 2011 founded, Unfunded company
- Reintegra - Alcobendas based, Unfunded company
- Pollen - San Francisco based, 2025 founded, Seed company
- MundoCorner.com - Unfunded company
